AIM2 and COVID-19: Our results showed a significant increase in the expression level of ZBP1 (P=0.0001), AIM2 (P<0.001), and MDA5 (P=0.003) genes in COVID-19 patients compared to the healthy control group (Figure 1(Fig. 1)).